Arcus Biosciences Stock Story
| RCUS Stock | USD 14.68 0.09 0.62% |
Slightly above 60% of Arcus Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Arcus Biosciences suggests that many traders are alarmed. Arcus Biosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Arcus Biosciences. The current market sentiment, together with Arcus Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Arcus Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Arcus Biosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Arcus daily returns and investor perception about the current price of Arcus Biosciences as well as its diversification or hedging effects on your existing portfolios.
Arcus |
Requested story not found. it has been either deleted or moved. View all stories for Arcus Biosciences.
Arcus Biosciences Latest Timeline
Arcus Biosciences is listed for 14.68. The company reported the previous year's revenue of 117 M. Net Loss for the year was (307 M) with loss before overhead, payroll, taxes, and interest of (176 M).Check out Arcus Biosciences Hype Analysis, Arcus Biosciences Correlation and Arcus Biosciences Performance. For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Arcus Stock analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |
Is Arcus Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcus Biosciences. If investors know Arcus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcus Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.15) | Revenue Per Share 1.581 | Quarterly Revenue Growth (0.09) | Return On Assets (0.17) | Return On Equity (0.55) |
The market value of Arcus Biosciences is measured differently than its book value, which is the value of Arcus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcus Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcus Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcus Biosciences' market value can be influenced by many factors that don't directly affect Arcus Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcus Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcus Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcus Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.